Search results
14 mar 2023 · The available data suggest that high MPV is related to better survival in renal cancer (two out of two studies), bladder cancer (one out of one study), and multiple myeloma (one out of one study) (see the “Results” section). The relation between cancer and MPV is bidirectional and is analyzed below (Figure 2).
- Platelets as messengers of early-stage cancer - PMC
However, MPV was 8.31 fL (range 7.53–9.09) or 7.8 fL (range...
- Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the ...
The authors showed that both the MPV value and the MPV/PLT...
- Relation of Mean Platelet Volume (MPV) with Cancer: A ... - PubMed
Most studies in gastric, breast, endometrium, thyroid, and...
- Platelets as messengers of early-stage cancer - PMC
26 lut 2021 · However, MPV was 8.31 fL (range 7.53–9.09) or 7.8 fL (range 6.2–11.3) in patients with gastric or endometrium cancer, respectively, whereas in healthy controls, MPV was 7.85 fL (range 7.4–8.3) and 7.2 fL (range 1.6–14.9), respectively.
Most studies in gastric, breast, endometrium, thyroid, and lung cancer documented an elevated MPV in cancer patients. Data were less clear-cut for esophageal, ovarian, and colon cancer, while reduced MPV was observed in renal cell carcinoma and gallbladder cancer.
17 kwi 2019 · The authors showed that both the MPV value and the MPV/PLT ratio were significantly higher in patients with carcinoma than in healthy patients. In the study group, the marker was the highest among women.
14 mar 2023 · Most studies in gastric, breast, endometrium, thyroid, and lung cancer documented an elevated MPV in cancer patients. Data were less clear-cut for esophageal, ovarian, and colon cancer, while reduced MPV was observed in renal cell carcinoma and gallbladder cancer.
11 sty 2022 · An elevated platelet count has been shown to be associated with short-term risk of cancer in the general population. 6-8 Prospective studies evaluating platelet count and survival among patients with newly diagnosed cancer have also noted a high proportion of patients who presented with thrombocytosis. 9-12 The excess risk associated with an ...
26 lut 2021 · However, MPV was 8.31 fL (range 7.53–9.09) or 7.8 fL (range 6.2–11.3) in patients with gastric or endometrium cancer, respectively, whereas in healthy controls, MPV was 7.85 fL (range 7.4–8.3) and 7.2 fL (range 1.6–14.9), respectively.
